[血清生物标志物在胃癌早期诊断中的研究进展]
[Advances in serum biomarkers for early diagnosis of gastric cancer].
作者信息
Zhang Yunzhu, Zhu Chunpeng, Lu Xinliang
机构信息
Department of Gastroenterology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
出版信息
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 May 25;48(3):326-333. doi: 10.3785/j.issn.1008-9292.2019.06.14.
Abstract
Early diagnosis is the key to improve the prognosis of gastric cancer. How to screen out high-risk subjects of gastric cancer in population is a hot spot. Serum-based early detection of gastric cancer is suitable for high-risk population screening, which is more convenient and safer. This article reviews the diagnostic value of serum biomarkers for gastric cancer, including serum DNA methylation, various RNAs, pepsinogen, gastrin, osteopontin, MG7-Ag and CA724. Until now, there is still lack of ideal biomarkers for gastric cancer, and searching for specific RNAs may be promising for early diagnosis and screening of gastric cancer.
摘要
早期诊断是改善胃癌预后的关键。如何在人群中筛查出胃癌高危人群是一个热点问题。基于血清的胃癌早期检测适用于高危人群筛查，更加便捷和安全。本文综述了血清生物标志物对胃癌的诊断价值，包括血清DNA甲基化、各种RNA、胃蛋白酶原、胃泌素、骨桥蛋白、MG7-Ag和CA724。到目前为止，仍然缺乏理想的胃癌生物标志物，寻找特异性RNA可能对胃癌的早期诊断和筛查具有前景。
相似文献
1
[Advances in serum biomarkers for early diagnosis of gastric cancer].[血清生物标志物在胃癌早期诊断中的研究进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 May 25;48(3):326-333. doi: 10.3785/j.issn.1008-9292.2019.06.14.
2
Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.检测三叶因子家族蛋白的血清水平可以提高胃癌的筛查效果。
Gastroenterology. 2011 Sep;141(3):837-845.e1-7. doi: 10.1053/j.gastro.2011.05.040. Epub 2011 May 27.
3
Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.抗幽门螺杆菌抗体联合血清 CA724、CA19-9 和 CEA 对青年早期胃癌患者的诊断和预后价值。
J Clin Lab Anal. 2020 Jul;34(7):e23268. doi: 10.1002/jcla.23268. Epub 2020 Mar 2.
4
Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.血清胃泌素及胃蛋白酶原I/II比值作为胃癌前病变诊断标志物
Asian Pac J Cancer Prev. 2013;14(6):3931-6. doi: 10.7314/apjcp.2013.14.6.3931.
5
DNA methylation biomarkers in serum for gastric cancer screening.血清中用于胃癌筛查的 DNA 甲基化生物标志物。
Mini Rev Med Chem. 2010 Oct;10(11):1034-8. doi: 10.2174/1389557511009011034.
6
Accuracy of screening for gastric cancer using serum pepsinogen concentrations.使用血清胃蛋白酶原浓度筛查胃癌的准确性。
Gut. 1999 May;44(5):693-7. doi: 10.1136/gut.44.5.693.
7
Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.血清三叶因子3是一种很有前景的用于胃癌筛查的非侵入性生物标志物：一项中国的单中心队列研究。
BMC Gastroenterol. 2014 Apr 11;14:74. doi: 10.1186/1471-230X-14-74.
8
Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening.应用血清免疫-PCR 法检测高危人群胃癌相关 MG7-Ag 的研究，及其在筛查中的意义。
Int J Cancer. 2010 Jan 15;126(2):469-73. doi: 10.1002/ijc.24739.
9
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.基于人群的早期胃癌筛查中血清胃蛋白酶原 I、胃蛋白酶原 II 和胃泌素-17 水平的诊断价值。
J Int Med Res. 2020 Mar;48(3):300060520914826. doi: 10.1177/0300060520914826.
10
Detection of serum gastric cancer-associated MG7-Ag from gastric cancer patients using a sensitive and convenient ELISA method.采用灵敏便捷的酶联免疫吸附测定（ELISA）法检测胃癌患者血清中的胃癌相关MG7抗原。
Cancer Invest. 2009 Feb;27(2):227-33. doi: 10.1080/07357900802175609.
引用本文的文献
1
Emerging roles of circ_NRIP1 in tumor development and cancer therapy (Review).环状核糖核酸NRIP1在肿瘤发生发展及癌症治疗中的新作用（综述）
Oncol Lett. 2023 Jun 8;26(1):321. doi: 10.3892/ol.2023.13907. eCollection 2023 Jul.
2
Prognosis of patients with early gastric carcinoma treated by endoscopic submucosal dissection and risk factors for additional postoperative surgery.早期胃癌内镜黏膜下剥离术治疗患者的预后及术后追加手术的危险因素
Am J Transl Res. 2022 May 15;14(5):3456-3463. eCollection 2022.
3
Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.阿帕替尼联合S-1治疗晚期胃癌患者的疗效及对肿瘤标志物水平和Th1及Th2样细胞因子的影响
Evid Based Complement Alternat Med. 2022 Apr 27;2022:8060026. doi: 10.1155/2022/8060026. eCollection 2022.
4
Knockdown of Gastrin Promotes Apoptosis of Gastric Cancer Cells by Decreasing ROS Generation.胃泌素敲低通过减少 ROS 生成促进胃癌细胞凋亡。
Biomed Res Int. 2021 Apr 14;2021:5590037. doi: 10.1155/2021/5590037. eCollection 2021.
5
Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer.血浆游离DNA作为评估胃癌化疗疗效的潜在生物标志物。
Cancer Manag Res. 2020 May 5;12:3099-3106. doi: 10.2147/CMAR.S243320. eCollection 2020.
本文引用的文献
1
Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.胃癌中的表观遗传机制与事件——新兴的新型生物标志物
Pathol Oncol Res. 2018 Oct;24(4):757-770. doi: 10.1007/s12253-018-0410-z. Epub 2018 Mar 19.
2
Exosomal long noncoding RNA HOTTIP as potential novel diagnostic and prognostic biomarker test for gastric cancer.外泌体长链非编码 RNA HOTTIP 作为胃癌潜在的新型诊断和预后生物标志物检测。
Mol Cancer. 2018 Feb 27;17(1):68. doi: 10.1186/s12943-018-0817-x.
3
Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值和癌胚抗原单独及联合用于诊断胃癌。
Clin Chim Acta. 2018 Jun;481:20-24. doi: 10.1016/j.cca.2018.02.027. Epub 2018 Feb 21.
4
Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.正常组织中的遗传和表观遗传改变对不同组织的癌症风险有不同的影响。
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1328-1333. doi: 10.1073/pnas.1717340115. Epub 2018 Jan 22.
5
Diagnostic accuracy of DNA methylation in detection of gastric cancer: a meta-analysis.DNA甲基化检测胃癌的诊断准确性：一项荟萃分析。
Oncotarget. 2017 Nov 3;8(68):113142-113152. doi: 10.18632/oncotarget.22613. eCollection 2017 Dec 22.
6
Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.MLH1启动子的表观遗传沉默与胃癌发生的关系及其作为微卫星不稳定患者生物标志物的应用：一项系统分析
Cell Physiol Biochem. 2018;45(1):148-162. doi: 10.1159/000486354. Epub 2018 Jan 15.
7
Long noncoding RNA LINC00978 promotes cancer growth and acts as a diagnostic biomarker in gastric cancer.长链非编码RNA LINC00978促进癌症生长并作为胃癌的诊断生物标志物。
Cell Prolif. 2018 Feb;51(1). doi: 10.1111/cpr.12425. Epub 2017 Dec 21.
8
Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection.利用血液样本检测肿瘤相关基因的启动子甲基化作为胃癌检测的潜在生物标志物。
Oncotarget. 2017 Sep 8;8(44):77783-77793. doi: 10.18632/oncotarget.20782. eCollection 2017 Sep 29.
9
A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.血清外泌体微小RNA检测 panel作为胃癌的潜在生物标志物检测方法
Biochem Biophys Res Commun. 2017 Nov 25;493(3):1322-1328. doi: 10.1016/j.bbrc.2017.10.003. Epub 2017 Oct 3.
10
Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.矮小同源盒2甲基化作为支气管吸出物中肺癌诊断的潜在非侵入性生物标志物。
Oncotarget. 2017 May 22;8(37):61253-61263. doi: 10.18632/oncotarget.18056. eCollection 2017 Sep 22.
Zotero 插件